Alaethes Wealth’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Alaethes Wealth’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,341	Closed	-$676K	–	116
2024 Q1	$676K	Hold	19,341	–	–	0.3%	88
2023 Q4	$735K	Hold	19,341	–	–	0.35%	91
2023 Q3	$355K	Hold	19,341	–	–	0.19%	95
2023 Q2	$502K	Hold	19,341	–	–	0.28%	91
2023 Q1	$365K	Hold	19,341	–	–	0.21%	97
2022 Q4	$477K	Hold	19,341	–	–	0.33%	84
2022 Q3	$347K	Hold	19,341	–	–	0.26%	90
2022 Q2	$220K	Hold	19,341	–	–	0.16%	98
2022 Q1	$431K	Hold	19,341	–	–	0.27%	87
2021 Q4	$845K	Hold	19,341	–	–	0.53%	75
2021 Q3	$644K	Hold	19,341	–	–	0.47%	74
2021 Q2	$532K	Sell	19,341 -10,000	-34%	-$208K	0.41%	73
2021 Q1	$589K	Buy	+29,341	New	+$857K	0.55%	69

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Alaethes Wealth's INBX Position: Q2 2024 in Review

Alaethes Wealth sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 19,341 shares — an estimated $676K sold.

Alaethes Wealth first reported a position in INBX in Q1 2021 and held it in 13 quarters. The position peaked at $845K in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Alaethes Wealth reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Alaethes Wealth sold 19,341 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $676K.
Alaethes Wealth first reported a position in Inhibrx, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
Alaethes Wealth's Inhibrx, Inc. Common Stock position peaked at $845K in Q4 2021.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Alaethes Wealth's 13F filing for Q2 2024, filed 13 Aug 2024.